Literature DB >> 7269559

Psychopharmacology in medical practice--the benefits and the risks.

R L Sack, J H Shore.   

Abstract

Psychopharmacology has become a major approach to treatment in primary medical care. However, combined psychiatric and medical illness can give rise to some challenging diagnostic problems. Furthermore, drug treatment of patients with such illnesses can involve important drug-disease interactions and drug-drug interactions. One should keep in mind the issues that arise when an emotionally troubled patient would benefit from a psychotropic drug but a concurrent medical illness complicates this treatment. An awareness of both the medical and psychiatric issues involved may make successful treatment possible.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7269559      PMCID: PMC1272608     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  54 in total

Review 1.  Cardiovascular complications of antidepressant therapy. Interactions at the adrenergic neuron.

Authors:  I H Raisfeld
Journal:  Am Heart J       Date:  1972-01       Impact factor: 4.749

2.  Chlorpromazine reversal of the antihypertensive action of guanethidine.

Authors:  W E Fann; D S Janowsky; J M Davis; J A Oates
Journal:  Lancet       Date:  1971-08-21       Impact factor: 79.321

3.  The overmedicated society: forces in the marketplace for medical care.

Authors:  C Muller
Journal:  Science       Date:  1972-05-05       Impact factor: 47.728

4.  The reversal of anticholinergic drug-induced delirium and coma with physostigmine.

Authors:  J F Heiser; J C Gillin
Journal:  Am J Psychiatry       Date:  1971-02       Impact factor: 18.112

5.  Treatment of hypertension with pargyline hydrochloride.

Authors:  B F Levy
Journal:  Curr Ther Res Clin Exp       Date:  1966-07

6.  Psychoactive drug use. Patterns found in samples from a mental health clinic and a general medical clinic.

Authors:  L A Gottschalk; D E Bates; R A Fox; J M James
Journal:  Arch Gen Psychiatry       Date:  1971-11

7.  The use of pethidine and morphine in the presence of monoamine oxidase inhibitors.

Authors:  C D Evans-Prosser
Journal:  Br J Anaesth       Date:  1968-04       Impact factor: 9.166

8.  Modification of chlorpromazine metabolism by some other drugs frequently administered to psychiatric patients.

Authors:  F M Forrest; I S Forrest; M T Serra
Journal:  Biol Psychiatry       Date:  1970-01       Impact factor: 13.382

Review 9.  Norepinephrine in depressive reactions. A review.

Authors:  W E Bunney; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1965-12

10.  Chlordiazepoxide and oxazepam disposition in cirrhosis.

Authors:  E M Sellers; D J Greenblatt; H G Giles; C A Naranjo; H Kaplan; S M MacLeod
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.